NDC properties for "Fortesta 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT" (RxCUI 1596783)
About this data
The tables show NDC propoerties for Fortesta 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT with the RxCUI 1596783
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Fortesta 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT (RxCUI 1596783)
| MMSL_CODE | BD26780 |
|---|---|
| NDA | NDA021463 |
| RxCUI | 1596783 |
| SPL_SET_ID | 053a7300-0bce-11e0-9d16-0002a5d5c51b |
| Prescribable Synonym | FORTESTA 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT |
| RXNAV_STR | Fortesta 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT |
| RxNorm Name | 120 ACTUAT testosterone 10 MG/ACTUAT Topical Gel [Fortesta] |
| RxNorm Synonym | Fortesta 10 MG/ACTUAT Transdermal Gel Pump, 120 ACTUAT |
| Related queries | Interactions (for RxCUI 1596783) |
NDC Properties
NDC Item 63481018316
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-16 |
| NDC Item | 63481018316 |
| Packaging | 1 CANISTER in 1 CARTON (63481-183-16) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018317
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-17 |
| NDC Item | 63481018317 |
| Packaging | 2 CANISTER in 1 CARTON (63481-183-17) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018318
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-18 |
| NDC Item | 63481018318 |
| Packaging | 3 CANISTER in 1 CARTON (63481-183-18) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018316
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-16 |
| NDC Item | 63481018316 |
| Packaging | 1 CANISTER in 1 CARTON (63481-183-16) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018317
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-17 |
| NDC Item | 63481018317 |
| Packaging | 2 CANISTER in 1 CARTON (63481-183-17) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018318
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-18 |
| NDC Item | 63481018318 |
| Packaging | 3 CANISTER in 1 CARTON (63481-183-18) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018316
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-16 |
| NDC Item | 63481018316 |
| Packaging | 1 CANISTER in 1 CARTON (63481-183-16) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018317
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-17 |
| NDC Item | 63481018317 |
| Packaging | 2 CANISTER in 1 CARTON (63481-183-17) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |
NDC Item 63481018318
| NDC 9 | 63481-183 |
|---|---|
| NDC 10 | 63481-183-18 |
| NDC Item | 63481018318 |
| Packaging | 3 CANISTER in 1 CARTON (63481-183-18) / 60 g in 1 CANISTER |
| DCSA | CIII |
| FDA SPL set id | 751181 |
| Labeler | ENDO USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2010-12-29 |
| Marketing status | ACTIVE |
| NDA | NDA021463 |
| Related queries | Properties for NDC 9 63481-183 |